DSpace at RU >

Browsing by Author Verhoef, S.

Full Text	Issue Date	Title	Author(s)
	2011	Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers	Ramus, S.J.; Kartsonaki, C.; Gayther, S.A.; Pharoah, P.D.; Sinilnikova, O.M., et al
	2011	Exploring the link between MORF4L1 and risk of breast cancer.	Martrat, G.; Maxwell, C.M.; Tominaga, E.; Porta-de-la-Riva, M.; Bonifaci, N., et al
	2011	Distress in partners of individuals diagnosed with or at high risk of developing tumors due to rare hereditary cancer syndromes	Lammens, C.R.; Bleiker, E.M.; Verhoef, S.; Ausems, M.G.; Majoor-Krakauer, D., et al
	2011	A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients	Didraga, M.A.; Beers, E.H. van; Joosse, S.A.; Brandwijk, K.I.; Oldenburg, R.A., et al
	2011	Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2	Osorio, A.; Milne, R.L.; Alonso, R.; Pita, G.; Peterlongo, P., et al
	2011	Compliance with periodic surveillance for Von-Hippel-Lindau disease	Lammens, C.R.; Aaronson, N.K.; Hes, F.J.; Links, T.P.; Zonnenberg, B.A., et al
	2011	Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers	Spurdle, A.B.; Marquart, L.; McGuffog, L.; Healey, S.; Sinilnikova, O., et al
	2010	Genetic testing in Li-Fraumeni syndrome: uptake and psychosocial consequences.	Lammens, C.R.; Aaronson, N.K.; Wagner, A.; Sijmons, R.H.; Ausems, M.G.E.M., et al
	2010	TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.	Ruijs, M.W.; Verhoef, S.; Rookus, M.A.; Pruntel, R.; Hout, A.H. van der, et al
	2010	Psychosocial impact of Von Hippel-Lindau disease: levels and sources of distress.	Lammens, C.R.; Bleiker, E.M.; Verhoef, S.; Hes, F.J.; Ausems, M.G., et al
	2010	Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers.	Pijpe, A.; Manders, P.; Brohet, R.M.; Collee, J.M.; Verhoef, S., et al
	2010	Regular surveillance for Li-Fraumeni Syndrome: advice, adherence and perceived benefits.	Lammens, C.R.; Bleiker, E.M.A.; Aaronson, N.K.; Wagner, A.; Sijmons, R.H., et al
	2009	A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history.	Gomez Garcia, E.B.; Oosterwijk-Wakka, J.C.; Timmermans, M.; Asperen, C.J. van; Hogervorst, F.B.L., et al
	2009	Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).	Osorio, A.; Milne, R.L.; Pita, G.; Peterlongo, P.; Heikkinen, T., et al
	2009	Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome.	Wijnen, J.T.; Brohet, R.M.; Eijk, R. van; Jagmohan-Changur, S.; Middeldorp, A., et al
	2009	Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH.	Joosse, S.A.; Beers, E.H. van; Tielen, I.H.; Horlings, H.; Peterse, J.L., et al
	2009	A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example	Mohammadi, L.; Vreeswijk, M.P.; Oldenburg, R.; Ouweland, A.M.W. van den; Oosterwijk-Wakka, J.C., et al
	2009	Attitude towards pre-implantation genetic diagnosis for hereditary cancer.	Lammens, C.; Bleiker, E.M.A.; Aaronson, N.K.; Vriends, A.H.; Ausems, M.G.E.M., et al
	2006	A multiplex PCR predictor for aCGH success of FFPE samples.	Beers, E.H. van; Joosse, S.A.; Ligtenberg, M.J.L.; Fles, R.; Hogervorst, F.B.L., et al
	2006	A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting.	Hout, A.H. van der; Ouweland, A.M.W. van den; Luijt, R.B. van der; Gille, H.J.; Bodmer, D., et al
	2005	Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.	Asperen, C.J. van; Brohet, R.M.; Meijers-Heijboer, E.J.; Hoogerbrugge-van der Linden, N.; Verhoef, S., et al
	2005	Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP).	Nielsen, M.; Franken, P.F.; Reinards, T.H.; Weiss, M.M.; Wagner, A., et al
	1996	Fatale hartritmestoornis na toediening van suxamethonium aan een kraamvrouw die achteraf dystrophia myotonica bleek te hebben	Wildschut, H.I.J.; Verhoef, S.; Schilder, J.L.A.M.; Hamel, B.C.J.